These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26455555)

  • 1. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students.
    Maier LJ; Haug S; Schaub MP
    Drug Alcohol Depend; 2015 Nov; 156():221-227. PubMed ID: 26455555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and motives for pharmacological neuroenhancement in Switzerland--results from a national Internet panel.
    Maier LJ; Haug S; Schaub MP
    Addiction; 2016 Feb; 111(2):280-95. PubMed ID: 26189457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological neuroenhancement and the ability to recover from stress - a representative cross-sectional survey among the German population.
    Bagusat C; Kunzler A; Schlecht J; Franke AG; Chmitorz A; Lieb K
    Subst Abuse Treat Prev Policy; 2018 Oct; 13(1):37. PubMed ID: 30348181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students.
    Maier LJ; Liechti ME; Herzig F; Schaub MP
    PLoS One; 2013; 8(11):e77967. PubMed ID: 24236008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical Cognitive Enhancement in Greek University Students: Differences Between Users and Non-Users in Social Cognitive Variables, Burnout, and Engagement.
    Lazuras L; Ypsilanti A; Lamprou E; Kontogiorgis C
    Subst Use Misuse; 2017 Jun; 52(7):950-958. PubMed ID: 28426360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological cognitive enhancement among non-ADHD individuals-A cross-sectional study in 15 countries.
    Maier LJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2018 Aug; 58():104-112. PubMed ID: 29902691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement.
    Maier LJ; Liakoni E; Schildmann J; Schaub MP; Liechti ME
    PLoS One; 2015; 10(12):e0144402. PubMed ID: 26657300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Questionnaire Survey Concerning Pharmacological Cognitive Enhancement among Undergraduates].
    Yamamoto M; Ishii Y
    Yakugaku Zasshi; 2020; 140(11):1397-1403. PubMed ID: 33132276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-medical use of prescription drugs and its association with socio-demographic characteristics, dietary pattern, and perceived academic load and stress in college students in Puerto Rico.
    Betancourt J; Ríos JL; Pagán I; Fabián C; González AM; Cruz SY; González MJ; Rivera WT; Palacios C
    P R Health Sci J; 2013 Jun; 32(2):89-94. PubMed ID: 23781625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building Conceptions of Cognitive Enhancement: University Students' Views on the Effects of Pharmacological Cognitive Enhancers.
    London-Nadeau K; Chan P; Wood S
    Subst Use Misuse; 2019; 54(6):908-920. PubMed ID: 30658557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland.
    Singh I; Bard I; Jackson J
    PLoS One; 2014; 9(10):e105969. PubMed ID: 25356917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-the-counter stimulant, depressant, and nootropic use by veterinary students.
    Hofmeister EH; Muilenburg JL; Kogan L; Elrod SM
    J Vet Med Educ; 2010; 37(4):403-16. PubMed ID: 21135409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the issues of neuroenhancement].
    Hinterhuber H
    Neuropsychiatr; 2010; 24(4):275-8. PubMed ID: 21176709
    [No Abstract]   [Full Text] [Related]  

  • 14. Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping".
    Wolff W; Brand R
    Subst Abuse Treat Prev Policy; 2013 Jun; 8():23. PubMed ID: 23777577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Medical Prescription Stimulant Use in Graduate Students: Relationship With Academic Self-Efficacy and Psychological Variables.
    Verdi G; Weyandt LL; Zavras BM
    J Atten Disord; 2016 Sep; 20(9):741-53. PubMed ID: 24756173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation.
    Earleywine M; Bolles JR
    J Psychoactive Drugs; 2014; 46(3):171-7. PubMed ID: 25052875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced self-control leads to disregard of an unfamiliar behavioral option: an experimental approach to the study of neuroenhancement.
    Wolff W; Baumgarten F; Brand R
    Subst Abuse Treat Prev Policy; 2013 Dec; 8():41. PubMed ID: 24314053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background.
    Weiergräber M; Ehninger D; Broich K
    Med Monatsschr Pharm; 2017 Apr; 40(4):154-64. PubMed ID: 29952165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Drug Alcohol Depend; 2013 Dec; 133(2):352-9. PubMed ID: 23886472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.